- Presentations
- 7
- Markets
- 1
Brixadi is a brand of Buprenorphine marketed by Braeburn, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Buprenorphine
- Brand owner
- Braeburn
- Registered in
- United States
- Strengths and forms
- 128 mg/0.36 mL injection, 16 mg/0.32 mL injection, 24 mg/0.48 mL injection, 32 mg/0.64 mL injection, 64 mg/0.18 mL injection, 8 mg/0.16 mL injection, 96 mg/0.27 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Brixadi 128 mg/0.36 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
| Brixadi 16 mg/0.32 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
| Brixadi 24 mg/0.48 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
| Brixadi 32 mg/0.64 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
| Brixadi 64 mg/0.18 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
| Brixadi 8 mg/0.16 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
| Brixadi 96 mg/0.27 mL injectionSubcutaneous | Braeburn | US FDA | Available on request |
Equivalent brands
Other brands of Buprenorphine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Brixadi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.